Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026
Pelthos Therapeutics, a commercial-stage biopharmaceutical company specializing in cutaneous infectious disease treatments, will report its first quarter 2026 financial results on May 14, 2026. The company will host a conference call to discuss the results and answer questions. Pelthos markets products including ZELSUVMI™, Xepi®, and Xeglyze® that …